High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains. [PDF]
Kikawa C +12 more
europepmc +1 more source
Neutralizers of Human Viruses in Animal Serums
openaire +1 more source
Monkeypox Virus Antibodies in Healthy Persons after Vaccination with MVA-BN, United Kingdom. [PDF]
Sheridan VH +6 more
europepmc +1 more source
Optimally fixed F protein on the surface of RSV-infected cells for RSV binding and neutralizing assays. [PDF]
Qiang H +9 more
europepmc +1 more source
Immunogenicity of SARS-CoV-2 vaccine prototype based on virus-like particles of hepatitis B core antigen from genotype G and interleukin 12 expressing Semliki Forest virus as a genetic adjuvant. [PDF]
Dislers A +10 more
europepmc +1 more source
Novel assays to assess the prevalence and neutralizing potential of anti-IdeS antibodies in healthy humans. [PDF]
Hannachi E +9 more
europepmc +1 more source
Immunogenic relationship mapping supports a minimal-set trivalent vaccine strategy for broad sarbecovirus protection. [PDF]
Sun Y +7 more
europepmc +1 more source
Serological Assays to Measure Rabies Antibody Response in Equine Serum Samples. [PDF]
Beniwal N +18 more
europepmc +1 more source
SARS-CoV-2 fusion-peptide-directed antibodies are elicited by natural infection and can mediate broad sarbecovirus neutralization. [PDF]
Roederer AL +8 more
europepmc +1 more source
Standardized neutralizing antibody assay for Coxsackievirus A10 in clinical trial: A framework for multivalent hand, foot, and mouth disease vaccine evaluation. [PDF]
Wang Q +19 more
europepmc +1 more source

